Skip to main content
Clinical Trials/NCT01163877
NCT01163877CompletedNot Applicable

Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or Schistosoma.

Swiss Federal Institute of Technology2 sites in 2 countries43 target enrollmentStarted: April 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
43
Locations
2
Primary Endpoint
Isotope absorption into blood stream

Study Overview

Brief Summary

The aim of this study is to investigate the change in iron metabolism in relation to malaria and helminth infections using a stable isotope technique.

Detailed Description

The aim of the study is to determine how iron metabolism in subjects with infectious diseases (malaria, hookworm or S. haematobium) differs while infected and after treatment, i.e. the same individuals will be restudied while free of infection.

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
12 Years to 16 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Children aged 12 to 16 years
  • Body weight > 30 kg
  • no chronic medical illnesses
  • no intake of vitamin/mineral supplements 2 weeks before the study and until the last blood drawing
  • For each of the 4 arms the respective disease needs to be present (symptomatic malaria, asymptomatic malaria, hookworm infection, S. haematobium infection) without any other concurrent infection

Exclusion Criteria

  • Not provided

Arms & Interventions

Symptomatic malaria infection

Other

Intervention: Fe-57 orally, Fe-58 intravenously (Dietary Supplement)

Asymptomatic malaria infection

Other

Intervention: Fe-57 orally, Fe-58 intravenously (Dietary Supplement)

Hookworm infection

Other

Intervention: Fe-57 orally, Fe-58 intravenously (Dietary Supplement)

Schistosoma haematobium infection

Other

Intervention: Fe-57 orally, Fe-58 intravenously (Dietary Supplement)

Outcomes

Primary Outcomes

Isotope absorption into blood stream

Time Frame: Day 43

Secondary Outcomes

  • Biochemical parameters of iron status and infection(Day 43)
  • Isotope incorporation into erythrocytes(Day 43)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Prof. Michael B. Zimmermann

Prof

Swiss Federal Institute of Technology

Study Sites (2)

Loading locations...

Similar Trials